Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$1.62 USD
-0.06 (-3.57%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $1.64 +0.02 (1.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Autolus Therapeutics PLC Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AUTL 1.62 -0.06(-3.57%)
Will AUTL be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AUTL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AUTL
AUTL's price falls by 2.33% on October 16, though its technical setup remains stable.
Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush
Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush
Crossed Above 50 Day Moving Average appears for AUTL after 6.17% move
Needham Hosts Virtual Meeting Featuring AUTL on October 22